We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals

237 hedge funds and large institutions have $6.73B invested in Alnylam Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 22

80% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 59

33% more call options, than puts

Call options by funds: $84.9M | Put options by funds: $63.7M

20% more funds holding in top 10

Funds holding in top 10: 1012 (+2)

20% more capital invested

Capital invested by funds: $5.62B → $6.73B (+$1.11B)

10% more funds holding

Funds holding: 215237 (+22)

Holders
237
Holders Change
+22
Holders Change %
+10.23%
% of All Funds
6.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.32%
New
47
Increased
106
Reduced
59
Closed
22
Calls
$84.9M
Puts
$63.7M
Net Calls
+$21.2M
Net Calls Change
+$5.1M
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$13.8M +$837K +8,256 +7%
TCM
52
Tekla Capital Management
Massachusetts
$13.6M +$6.95M +68,600 +111%
TCM
53
TimesSquare Capital Management
New York
$13.6M +$50.7K +500 +0.4%
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
$13.1M +$186K +1,839 +1%
Charles Schwab
55
Charles Schwab
California
$12.8M +$1.78M +17,548 +17%
Allianz Asset Management
56
Allianz Asset Management
Germany
$10.8M +$2.33M +23,000 +29%
TA
57
Teachers Advisors
New York
$10.1M +$5.12M +50,490 +108%
State Board of Administration of Florida Retirement System
58
State Board of Administration of Florida Retirement System
Florida
$9.54M -$238K -2,352 -3%
California Public Employees Retirement System
59
California Public Employees Retirement System
California
$9.45M
CNB
60
City National Bank
California
$9.19M +$2.16M +21,318 +32%
TAM
61
Tocqueville Asset Management
New York
$8.73M +$5.61M +55,335 +196%
Swiss National Bank
62
Swiss National Bank
Switzerland
$8.65M +$1.13M +11,200 +16%
Massachusetts Financial Services
63
Massachusetts Financial Services
Massachusetts
$8.59M +$258K +2,548 +3%
BG
64
BlackRock Group
United Kingdom
$8.33M +$4.27M +42,120 +112%
Millennium Management
65
Millennium Management
New York
$8.3M +$8.06M +79,515 New
Citigroup
66
Citigroup
New York
$8.22M +$4.85M +47,827 +155%
ProShare Advisors
67
ProShare Advisors
Maryland
$7.44M +$1.7M +16,728 +31%
Axa
68
Axa
France
$7.14M +$489K +4,830 +8%
JHIU
69
Janus Henderson Investors US
Colorado
$7.12M +$5.65M +55,800 +450%
BNP Paribas Asset Management
70
BNP Paribas Asset Management
France
$7.11M -$10.2M -100,598 -60%
NFA
71
Nationwide Fund Advisors
Ohio
$6.81M -$611K -6,031 -8%
EAM
72
EverPoint Asset Management
Connecticut
$6.68M +$101K +1,000 +2%
BAMS
73
Bellevue Asset Management (Switzerland)
Switzerland
$6.68M +$6.49M +64,000 New
3NC
74
300 North Capital
California
$6.52M -$136K -1,345 -2%
JG
75
Jefferies Group
New York
$6.51M +$6.32M +62,324 New

ALNY Hedge Fund Activity: Q1 2015 in Review

237 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2015, worth a combined $6.73B — up 20% from $5.62B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 22 closed out — a net gain of 25 holders — while 106 added to existing stakes and 59 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $151M. The largest seller was Franklin Resources, cutting an estimated $103M.

  • 237 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2015, up from 215 in Q4 2014.
  • Funds reported $6.73B of Alnylam Pharmaceuticals stock for Q1 2015, up 20% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2015 and 22 closed out, a net change of +25 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2015 was Wellington Management Group, an estimated $151M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2015 was Franklin Resources, an estimated $103M sold.

Based on aggregated 13F filings for Q1 2015.